VNDAVanda Pharmaceuticals Inc.

Nasdaq vandapharma.com


$ 5.05 $ 0.01 (0.2 %)    

Monday, 13-May-2024 15:59:50 EDT
QQQ $ 442.84 $ 1.02 (0.23 %)
DIA $ 394.52 $ -0.72 (-0.18 %)
SPY $ 520.61 $ 0.07 (0.01 %)
TLT $ 90.36 $ 0.23 (0.26 %)
GLD $ 216.28 $ -2.45 (-1.12 %)
$ 5.05
$ 5.05
$ 0.00 x 0
$ 0.00 x 0
$ 4.97 - $ 5.14
$ 3.30 - $ 6.76
832,736
na
291.69M
$ 0.62
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-08-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 07-28-2023 06-30-2023 10-Q
5 05-03-2023 03-31-2023 10-Q
6 02-09-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 07-29-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 02-11-2021 12-31-2020 10-K
15 10-29-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-26-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-03-2019 03-31-2019 10-Q
22 02-19-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 02-15-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-03-2017 06-30-2017 10-Q
29 05-03-2017 03-31-2017 10-Q
30 02-17-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 07-28-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 02-12-2016 12-31-2015 10-K
35 11-04-2015 09-30-2015 10-Q
36 07-31-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 03-13-2015 12-31-2014 10-K
39 10-27-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 vanda-pharma-q1-2024-gaap-eps-007-misses-005-estimate-sales-47462m-miss-48500m-estimate

Vanda Pharma (NASDAQ:VNDA) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $0.05 ...

 vanda-pharmaceuticals-confirms-receipt-of-revised-unsolicited-takeover-proposal-from-future-pak-says-co-does-not-intend-to-comment-further-on-the-revised-unsolicited-proposal-before-the-board-has-completed-its-review

No Shareholder Action Required at This TimeWASHINGTON, May 7, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" ...

 vanda-pharmaceuticals-shareholder-sharecap-says-company-board-must-explore-strategic-alternatives

ShareCap calls on the Board to initiate a strategic alternatives process that, among the alternatives, reconsiders Future Pak&#...

 us-supreme-court-declines-to-hear-vanda-pharmaceuticals-case-regarding-invalidation-of-patents-for-its-sleep-disorder-drug-hetlioz

"Supreme Court denies review of Vanda Pharmaceuticals' patent revival attempt for Hetlioz sleep-disorder medication. Le...

Core News & Articles

https://finance.yahoo.com/news/1-u-supreme-court-rejects-153720025.htmlThe U.S. Supreme Court on Monday declined to hear a bid ...

 butler-hall-capital-has-issued-an-open-letter-to-vndas-board-of-directors-urging-the-company-to-run-a-full-sales-process-to-maximize-shareholder-value

https://ml.globenewswire.com/Resource/Download/9ee5bd01-bdbc-43f7-af2d-e4c34004b336Dear Members of the Board: A fund managed by...

 crude-oil-dips-3-us-bancorp-profit-tops-views

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday. The D...

 why-travelers-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.

 neuropsychiatric-focused-vanda-pharmaceuticals-rejects-future-paks-takeover-bid-valued-up-to-775share

Vanda Pharmaceuticals rebuffs unsolicited proposals from Future Pak LLC, citing undervaluation. Offers up to $7.75 per share. B...

 vanda-pharmaceuticals-adopts-1-year-term-limited-duration-stockholder-rights-plan-to-protect-stockholder-interests-and-maximize-value-for-all-stockholders-effective-immediately

Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (NASDAQ:VNDA) today announced that its Board of Directors...

 vanda-pharmaceuticals-confirms-rejection-of-unsolicited-takeover-proposals-from-future-pak-says-board-determined-unsolicited-takeover-proposals-significantly-undervalue-the-company

Board Determined Unsolicited Takeover Proposals Significantly Undervalue the CompanyNo Shareholder Action Required at This Time...

Core News & Articles
Market-Moving News for April 17th
04/17/2024 12:33:15

VNDA: 50% | Vanda Pharmaceuticals shares are trading higher after the company announced that it submitted three proposals since...

 nasdaq-gains-75-points-acuity-brands-posts-upbeat-earnings

U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 0.3% on Wednesday. The Dow traded up ...

 why-ulta-beauty-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION